Y-90 SIRT for Unresectable HCC Larger Than 7cm — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Y-90 SIRT for Unresectable HCC Larger Than 7cm — Stella

Recruiting

Back to Hepatocellular Carcinoma Non-Resectable trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(2 sites)

China

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Phase

Safety & dosing

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Enrollment target

~33 participants

Started

December 2024

Primary completion

November 2026

Age range

18 Years – 75 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov